Andrew Kidd

Andrew Kidd

Chief Executive Officer at Tentarix Biotherapeutics LP

Net worth: 9 700 $ as of 2023-12-30

48 year
Health Technology
Consumer Services

Profile

Andrew Kidd is currently the Chief Executive Officer at Tentarix Biotherapeutics LP.
Previously, he served as the CEO, Chief Financial & Accounting Officer at Aptinyx, Inc. from 2017 to 2023.
Prior to that, he held positions at Baxter International, Inc. as Vice President-Strategy & Business Development, and at Baxter Corp.
as General Manager.
Dr. Kidd completed his undergraduate studies at the University of Oxford and the University of Cambridge.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-04-23 101,043 ( 0.15% ) 9 700 $ 2023-12-30

Andrew Kidd active positions

CompaniesPositionStart
Chief Executive Officer 2024-04-22
All active positions of Andrew Kidd

Former positions of Andrew Kidd

CompaniesPositionEnd
APTINYX Chief Executive Officer 2023-06-29
Corporate Officer/Principal -
BAXTER INTERNATIONAL INC. Corporate Officer/Principal -
See the detail of Andrew Kidd's experience

Training of Andrew Kidd

University of Oxford Undergraduate Degree
University of Cambridge Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Kidd's experience

Connections

30

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BAXTER INTERNATIONAL INC.

Health Technology

APTINYX

Health Technology

Private companies2

Health Technology

Health Technology

See company connections